Correction to: HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines

Affiliations

Tobias S. Iveland: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology
Lars Hagen: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology
Animesh Sharma: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology
Mirta M. L. Sousa: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology
Antonio Sarno: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology
Kristian Lied Wollen: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology
Nina Beate Liabakk: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology
Geir Slupphaug: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology

Abstract

An amendment to this paper has been published and can be accessed via the original article.